Clinical Characterization of Korean Patients with Pseudoxanthoma Elasticum and Angioid Streaks

Genes (Basel). 2021 Aug 4;12(8):1207. doi: 10.3390/genes12081207.

Abstract

This study aimed to characterize Korean patients with pseudoxanthoma elasticum (PXE) presenting with angioid streaks. Retinal phenotypes were longitudinally evaluated by multimodal ophthalmic imaging, and targeted gene panel sequencing for inherited retinal diseases was conducted. Seven subjects from unrelated families (median age, 51.2 years) were enrolled and followed for a median of 3.2 years. Four asymptomatic patients were significantly younger than three symptomatic patients with decreased visual acuity at presentation (mean age; 38.1 vs. 61.5 years, p = 0.020). The asymptomatic patients maintained good vision (20/32 or better) and had no choroidal neovascularization (CNV) over the observation period. The symptomatic patients showed additional reduction in visual acuity and bilateral CNV occurrence during the longitudinal follow-up. Pathogenic ABCC6 variants were identified in all patients, leading to a diagnosis of PXE. Heterozygous monoallelic variants were identified in four patients and compound heterozygous variants were detected in three patients. Nine ABCC6 variants were identified, including one novel variant, c.2035G>T [p.Glu679Ter]. This is the first genetic study of Korean patients with PXE.

Keywords: ABCC6; Korean population; angioid streaks; pseudoxanthoma elasticum.

Publication types

  • Observational Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Angioid Streaks / diagnosis*
  • Angioid Streaks / genetics
  • Angioid Streaks / physiopathology
  • Choroidal Neovascularization
  • Female
  • Fluorescein Angiography
  • Heterozygote
  • Humans
  • Male
  • Middle Aged
  • Multidrug Resistance-Associated Proteins / genetics
  • Pseudoxanthoma Elasticum / diagnosis*
  • Pseudoxanthoma Elasticum / genetics
  • Pseudoxanthoma Elasticum / physiopathology
  • Republic of Korea
  • Retrospective Studies
  • Visual Acuity

Substances

  • ABCC6 protein, human
  • Multidrug Resistance-Associated Proteins